SCIESCOPUSQ3
Atherosclerosis Plus
ELSEVIER, Ireland
Atherosclerosis Plus is an academic journal published by ELSEVIER (Ireland). Identifiers: ISSN 2667-0909, eISSN 2667-0895. Indexed in SCIE, SCOPUS. Metrics: JIF 2.1, CiteScore 3.2, SJR 0.671, SNIP 0.67. Subject areas: PERIPHERAL VASCULAR DISEASE, PERIPHERAL VASCULAR DISEASES. tlooto lists 311 papers from this journal.
CiteScore
3.20
Scopus citation metric
SJR
0.671
SCImago rank
SNIP
0.67
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2667-0909
- eISSN
- 2667-0895
- Abbreviation
- ATHEROSCLEROSIS PLUS
- Publisher
- ELSEVIER
- Country
- Ireland
Web of Science categories
SCIEPERIPHERAL VASCULAR DISEASES
Scopus ASJC categories
2705 Cardiology and Cardiovascular Medicine2724 Internal Medicine
Keywords
Peripheral Vascular Diseases
Papers in this journal
Recent papers
- Real-world Cardiovascular Risk Estimation, Blood Pressure and LDL-Cholesterol Control: Two Epidemiological Studies in Romania, during pandemic and post-pandemic (SNAPSHOT-Romania)
2026
- Corrigendum to Neural network model outperforms conventional equations in LDL cholesterol estimation: A comparative study of 188,887 Chinese individuals with focus on hypertriglyceridemia [Atherosclerosis Plus, (62), December 2025, Pages 38-46].
2026
- Association between HIV infection and arterial stiffness: A population-based cross-sectional study from Rakai, South Western Uganda
2026
- Calciprotein particles disrupt autophagy in vascular endothelial cells and smooth muscle cells
2026
- Systematic literature review on the real-world effectiveness and safety of bempedoic acid
2026
Most cited papers
- Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
2021 · 32 citations
- Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
2023 · 31 citations
- HDL and chronic kidney disease
2023 · 29 citations
- High-density lipoproteins and non-alcoholic fatty liver disease
2023 · 28 citations
- High-density lipoprotein cholesterol: A marker of COVID-19 infection severity?
2021 · 26 citations